Survival outcomes in patients with metastatic castration-sensitive prostate cancer (mCSPC): A real-world evidence study.

被引：3

作者：

Freedland, Stephen J. ^{[1
]}

Sandin, Rickard ^{[2
]}

Sah, Janvi ^{[3
]}

Emir, Birol ^{[4
]}

Mu, Qiao ^{[3
]}

Ratiu, Anna ^{[3
]}

Hong, Agnes ^{[5
]}

Serfass, Lucile ^{[6
]}

Tagawa, Scott T. ^{[7
]}

机构：

[1] Vet Affairs Hlth Care Syst, Cedars Sinai Med Ctr, Dept Surg, Div Urol, Los Angeles, CA USA

[2] Pfizer AB, Sollentuna, Sweden

[3] STATinMED Res, Ann Arbor, MI USA

[4] Pfizer Inc, New York, NY USA

[5] Astellas Pharma Inc, Northbrook, IL USA

[6] Pfizer Inc, Paris, France

[7] New York Presbyterian Hosp, Weill Cornell Med Div Hematol & Med Oncol, New York, NY USA

来源：

JOURNAL OF CLINICAL ONCOLOGY | 2021年 / 39卷 / 06期

关键词：

D O I：

10.1200/JCO.2021.39.6_suppl.46

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

下载

页数：2

共 50 条

[1] Treatment patterns of metastatic castration-sensitive prostate cancer (mCSPC): A real-world evidence study
Tagawa, S. T.
Sandin, R.
Sah, J.
Mu, Q.
Freedland, S. J.
ANNALS OF ONCOLOGY, 2020, 31 : S541 - S542
[2] Real-world economic burden of patients with metastatic castration-sensitive prostate cancer (mCSPC)
Kaye, Deborah
Khilfeh, Ibrahim
Muser, Erik
Morrison, Laura
Urosevic, Ana
Kinkead, Frederic
Lefebvre, Patrick
Pilon, Dominic
George, Daniel J.
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 64 - 64
[3] Real-world survival of men with metastatic castration-sensitive prostate cancer (mCSPC) initiated on apalutamide (APA) or enzalutamide (ENZ) in an oncology database: ROME Study.
Bilen, Mehmet Asim
Du, Shawn
Khilfeh, Ibrahim
Rossi, Carmine
Korsiak, Jill
Rahman, Alvi
Lefebvre, Patrick
Pilon, Dominic
Shore, Neal D.
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 57 - 57
[4] Association of circulating tumor cells (CTC) with survival outcomes in patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC) in a real-world cohort.
Swami, Umang
McFarland, Taylor Ryan
Haaland, Benjamin
Kessel, Adam
Nussenzveig, Robert
Sayegh, Nicolas
Hahn, Andrew Warren
Rathi, Nityam
Sirohi, Deepika
Esther, John
Li Haoran
Kohli, Manish
Maughan, Benjamin Louis
Goldkorn, Amir
Agarwal, Neeraj
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (06)
[5] Analysis of real-world survival for patients with metastatic castration-sensitive prostate cancer (mCSPC) treated with apalutamide (APA) or abiraterone acetate (ABI) in an oncology database: ROMA study.
Bilen, Mehmet Asim
Khilfeh, Ibrahim
Rossi, Carmine
Du, Shawn
Korsiak, Jill
Rahman, Alvi
Lefebvre, Patrick
Pilon, Dominic
Shore, Neal D.
JOURNAL OF CLINICAL ONCOLOGY, 2024, 42 (4_SUPPL) : 58 - 58
[6] Real-world (RW) prevalence of adverse events (AEs) among patients (pts) with metastatic castration-sensitive prostate cancer (mCSPC).
Swami, Umang
Xie, Bin
Ramaswamy, Krishnan
El-Chaar, Nader N.
Gao, Wei
Yang, Hongbo
Wang, Yao
Young, Christopher
Mucha, Lisa
JOURNAL OF CLINICAL ONCOLOGY, 2023, 41
[7] Real-world clinical outcomes among patients with metastatic castration-sensitive prostate cancer initiating apalutamide
Lowentritt, Benjamin H.
Du, Shawn
Rossi, Carmine
Muser, Erik
Khilfeh, Ibrahim
Kinkead, Frederic
Korsiak, Jill
Lefebvre, Patrick
Pilon, Dominic
Agarwal, Neeraj
FUTURE ONCOLOGY, 2024,
[8] Evolving real-world patterns of practice in metastatic castration-sensitive prostate cancer (mCSPC): The genitourinary research consortium (GURC) national multicenter cohort study.
Yip, Steven
Niazi, Tamim
Hotte, Sebastien J.
Lavallee, Luke
Finelli, Antonio
Kapoor, Anil
Kolinsky, Michael Paul
Ong, Michael
Pouliot, Frederic
Antebi, Elie
Drachenberg, Darrel
Gotto, Geoffrey
Hamilton, Robert James
Noonan, Krista
Rendon, Ricardo A.
Shayegan, Bobby
Zardan, Anousheh
Chi, Kim N.
Saad, Fred
Morash, Chris
JOURNAL OF CLINICAL ONCOLOGY, 2022, 40 (06)
[9] Real-world evidence of triplet therapy efficacy in patients with metastatic castration-sensitive prostate cancer: a Japanese multicenter study
Urabe, Fumihiko
Imai, Yu
Goto, Yuma
Tashiro, Kojiro
Hashimoto, Masaki
Yoshihara, Kentaro
Yamamoto, Shutaro
Hara, Shuhei
Miyajima, Keiichiro
Fukuokaya, Wataru
Enei, Yuki
Iwatani, Kosuke
Kayano, Sotaro
Igarashi, Taro
Aikawa, Koichi
Yanagisawa, Takafumi
Kimura, Shoji
Tsuzuki, Shunsuke
Murakami, Masaya
Hata, Kenichi
Shimomura, Tatsuya
Yamada, Hiroki
Miki, Jun
Kimura, Takahiro
JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2024,
[10] Real-world treatment patterns among patients diagnosed with metastatic castration-sensitive prostate cancer (mCSPC) in community oncology settings.
George, Daniel J.
Agarwal, Neeraj
Rider, Jennifer R.
Li, Benjamin
Shirali, Rohan
Sandin, Rickard
Hong, Agnes
Russell, Dave
Ramaswamy, Krishnan
Freedland, Stephen J.
JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)

← 1 2 3 4 5 →